Tessera Therapeutics’ $230 million Series B Financing Round

Martina Bellini
Tagged:

Goodwin Procter LLP advised Tessera Therapeutics on the deal.Tessera Therapeutics, an early-stage life sciences company founded by Flagship Pioneering, announced today that it has raised over…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

…

This content is for Standard 1 Year members only.
Login Join Now